RRML - Multiparametric approach of prognostic factors in acute myeloid leukemia – a bicentric study
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English


Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12


Advanced search


Top 10 downloaded articles
- July 2024 -
 
A comprehensive review of Prof... 13
Romanian Review of Laboratory ... 7
Evaluation of routine laborato... 5
Monocyte to high-density lipop... 4
The role of nitro oxidative fa... 4
Diagnostic value of stress myo... 4
The frequency of EGFR gene mut... 4
Assessment of ocrelizumab impa... 4
Correlations of high miRNA exp... 4
The usefulness of IS6110 neste... 3

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 14(1)/2009
XML
TXT

Multiparametric approach of prognostic factors in acute myeloid leukemia – a bicentric study

Anca Bacârea, Mariana Paţiu, Andrei Cucuianu, Delia Dima, Vladimir Bacârea, Bogdana Dorcioman, Minodora Dobreanu, Galafteon Oltean


Abstract:

Acute myeloid leukemias (AML) are a group of malignant hematologic disorders with varying clinical, morphologic, immunologic and molecular characteristics. Prognostic factors evaluation remains an important subject of study in order to improve the outcome of patients with AML, a disease with poor prognostic by itself. Establishing prognosis at the time of diagnosis is expected in order to stratify treatment. The aim of this study is to evaluate some prognostic factors in AML: age, leukocyte count, platelet count, FAB (French-American-British Cooperative Group) subtype, LDH serum level, immunophenotype at diagnosis. We included 59 patients with primary or secondary AML at the time of diagnostic, with complete investigation at the Hematology Department of Medical Clinic I in Tg-Mureş and at the Hematology Department of “Ion Chiricuţă” Cancer Institute Cluj-Napoca. Our results indicate that leukocyte count over 100000/µL, LDH serum activities over 1000 U/L and C34+CD56+ association are significant prognostic factors in AML at the time of diagnostic. FAB subtypes M0, M1, M4 significantly influenced complete remission. Due to the low number of cases prognostic evaluation of cytogenetics and molecular findings is not possible. These results represent an intermediary evaluation of patients, because the study is still underway.

Keywords: AML,prognostic,immunophenotyping

 
  PDF Download full text PDF
(99 KB)
     
 
How to cite
Bacârea A, Paţiu M, Cucuianu A, Dima D, Bacârea V, Dorcioman B, et al. Multiparametric approach of prognostic factors in acute myeloid leukemia – a bicentric study. Rev Romana Med Lab. 2009;14(1):41-8